- Home
- RARE vs SM Comparison
RARE vs SM Comparison
Compare RARE & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- SM
- Stock Information
- Founded
- RARE 2010
- SM 1908
- Country
- RARE United States
- SM United States
- Employees
- RARE N/A
- SM N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- SM Oil & Gas Production
- Sector
- RARE Health Care
- SM Energy
- Exchange
- RARE Nasdaq
- SM Nasdaq
- Market Cap
- RARE 5.2B
- SM 4.9B
- IPO Year
- RARE 2014
- SM 1992
- Fundamental
- Price
- RARE $40.89
- SM $41.90
- Analyst Decision
- RARE Strong Buy
- SM Buy
- Analyst Count
- RARE 15
- SM 11
- Target Price
- RARE $92.00
- SM $51.80
- AVG Volume (30 Days)
- RARE 1.0M
- SM 1.5M
- Earning Date
- RARE 02-13-2025
- SM 02-19-2025
- Dividend Yield
- RARE N/A
- SM 1.91%
- EPS Growth
- RARE N/A
- SM 4.45
- EPS
- RARE N/A
- SM 7.15
- Revenue
- RARE $522,745,000.00
- SM $2,337,364,000.00
- Revenue This Year
- RARE $26.70
- SM $23.77
- Revenue Next Year
- RARE $19.02
- SM $22.19
- P/E Ratio
- RARE N/A
- SM $5.86
- Revenue Growth
- RARE 27.44
- SM 0.44
- 52 Week Low
- RARE $37.02
- SM $34.90
- 52 Week High
- RARE $60.37
- SM $53.26
- Technical
- Relative Strength Index (RSI)
- RARE 40.43
- SM 51.31
- Support Level
- RARE $39.99
- SM $43.21
- Resistance Level
- RARE $44.52
- SM $44.95
- Average True Range (ATR)
- RARE 2.18
- SM 1.12
- MACD
- RARE -0.03
- SM 0.36
- Stochastic Oscillator
- RARE 17.75
- SM 57.87
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and condensate, natural gas, and natural gas liquids. Operating primarily out of the United States, the company actively participates in joint ventures, prospects/leaseholds, and drill-to-earn opportunities. The majority of the company's revenue is derived from some of the United States' premier drilling locations. Drilling location interests have been traditionally obtained through oil and gas leases from third parties. SM Energy relies on its fleet of geologists, geophysicists, landmen, and engineers to help extract the full potential out of all properties held.